U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442058) titled 'Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD' on Feb. 11.
Brief Summary: Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies ...